Published in Gene Ther on December 23, 2010
Silencing disease genes in the laboratory and the clinic. J Pathol (2011) 1.72
Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias. Hum Mutat (2011) 1.35
Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides. Bioconjug Chem (2011) 1.32
Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia. Blood (2011) 1.24
Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisense. Mol Ther (2011) 1.03
Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target. Leukemia (2012) 1.00
Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology. Nucleic Acid Ther (2014) 0.90
Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2'-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents. Artif DNA PNA XNA (2012) 0.87
Development of bis-locked nucleic acid (bisLNA) oligonucleotides for efficient invasion of supercoiled duplex DNA. Nucleic Acids Res (2013) 0.85
A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells. Nucleic Acids Res (2015) 0.85
LNA-based oligonucleotide electrotransfer for miRNA inhibition. Mol Ther (2012) 0.84
Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic. Front Chem (2014) 0.84
Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression, or signaling. Cancer Res (2013) 0.83
Antisense 2'-Deoxy, 2'-Fluroarabino Nucleic Acids (2'F-ANAs) Oligonucleotides: In Vitro Gymnotic Silencers of Gene Expression Whose Potency Is Enhanced by Fatty Acids. Mol Ther Nucleic Acids (2012) 0.83
Acute targeting of general transcription factor IIB restricts cardiac hypertrophy via selective inhibition of gene transcription. Circ Heart Fail (2014) 0.81
Evaluation of multiple-turnover capability of locked nucleic acid antisense oligonucleotides in cell-free RNase H-mediated antisense reaction and in mice. Nucleic Acid Ther (2014) 0.81
Antisense growth inhibition of methicillin-resistant Staphylococcus aureus by locked nucleic acid conjugated with cell-penetrating peptide as a novel FtsZ inhibitor. Antimicrob Agents Chemother (2014) 0.80
Sub-cellular temporal and spatial distribution of electrotransferred LNA/DNA oligomer. J RNAi Gene Silencing (2013) 0.77
Correlating In Vitro Splice Switching Activity With Systemic In Vivo Delivery Using Novel ZEN-modified Oligonucleotides. Mol Ther Nucleic Acids (2014) 0.77
Protein Kinase C-α is a Critical Protein for Antisense Oligonucleotide-mediated Silencing in Mammalian Cells. Mol Ther (2016) 0.76
Dual inhibition of Type I and Type III PI3 kinases increases tumor cell apoptosis in HER2+ breast cancers. Breast Cancer Res (2015) 0.75
Ca2+ enrichment in culture medium potentiates effect of oligonucleotides. Nucleic Acids Res (2015) 0.75
6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer Cells. Mol Ther (2017) 0.75
Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol (2003) 16.63
The promises and pitfalls of RNA-interference-based therapeutics. Nature (2009) 7.53
3' UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods (2006) 6.96
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer (2009) 6.28
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol (2005) 5.99
Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci U S A (2004) 4.85
LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA. Biochemistry (2004) 3.41
Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA. Chem Biol (2001) 3.26
Antisense--down, but not out. Nat Biotechnol (2007) 2.43
Comparison of siRNA-induced off-target RNA and protein effects. RNA (2007) 2.22
Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents. Nucleic Acids Res (2009) 2.22
Targeting HER proteins in cancer therapy and the role of the non-target HER3. Br J Cancer (2007) 2.20
A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides. Biochim Biophys Acta (1999) 1.92
Promising nucleic acid analogs and mimics: characteristic features and applications of PNA, LNA, and morpholino. Appl Microbiol Biotechnol (2006) 1.61
A RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growth. Mol Cancer Ther (2008) 1.49
Locked nucleic acid: a potent nucleic acid analog in therapeutics and biotechnology. Oligonucleotides (2004) 1.37
The apical submembrane cytoskeleton participates in the organization of the apical pole in epithelial cells. J Cell Biol (1997) 1.31
Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides. Nucleic Acids Res (2000) 1.25
Locked nucleic acid oligonucleotides: the next generation of antisense agents? BioDrugs (2007) 1.20
Locked nucleic acid as a novel class of therapeutic agents. RNA Biol (2009) 1.17
SPC3042: a proapoptotic survivin inhibitor. Mol Cancer Ther (2008) 1.15
In vitro toxicology and pharmacokinetics of antisense oligonucleotides. Anticancer Drug Des (1991) 1.14
Transcriptional effects of transfection: the potential for misinterpretation of gene expression data generated from transiently transfected cells. Biotechniques (2009) 1.05
What have RNAi screens taught us about viral-host interactions? Curr Opin Microbiol (2009) 1.04
Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development. Curr Opin Mol Ther (2001) 1.01
Toxicology of antisense therapeutics. Toxicol Appl Pharmacol (2004) 1.00
c-myc antisense oligonucleotides sensitize human colorectal cancer cells to chemotherapeutic drugs. Tumour Biol (2008) 0.91
The involvement of human ribonucleases H1 and H2 in the variation of response of cells to antisense phosphorothioate oligonucleotides. Eur J Biochem (2002) 0.91
Applicator and electrode design for in vivo DNA delivery by electroporation. Methods Mol Biol (2008) 0.90
Antisense-based cancer therapeutics: are we there yet? Expert Opin Emerg Drugs (2006) 0.84
[Progress in locked nucleic acid research]. Sheng Li Ke Xue Jin Zhan (2003) 0.78
Genome cross-referencing and XREFdb: implications for the identification and analysis of genes mutated in human disease. Nat Genet (1997) 10.14
Room-temperature ultraviolet nanowire nanolasers. Science (2001) 9.79
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med (2001) 9.53
Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med (1995) 8.51
The genome of the natural genetic engineer Agrobacterium tumefaciens C58. Science (2001) 6.90
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med (2001) 6.73
Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture. Science (2010) 6.67
REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell (1995) 6.43
The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol (2001) 6.10
Radiation hybrid mapping: a somatic cell genetic method for constructing high-resolution maps of mammalian chromosomes. Science (1990) 5.35
Hard-X-ray dark-field imaging using a grating interferometer. Nat Mater (2008) 5.19
Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol (1999) 4.98
HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene (2012) 4.30
CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation. J Biol Chem (2001) 4.14
A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med (2000) 4.14
Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med (1997) 4.10
Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A (2000) 4.08
Specific and nonspecific NK cell activation during virus infection. Nat Immunol (2001) 4.02
Imaging membrane protein helical wheels. J Magn Reson (2000) 3.80
Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem (2000) 3.74
Highly constrained backprojection for time-resolved MRI. Magn Reson Med (2006) 3.53
"Fluorescent timer": protein that changes color with time. Science (2000) 3.42
Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med (1996) 3.34
Structural basis of the redox switch in the OxyR transcription factor. Cell (2001) 3.32
Inhibition of human immunodeficiency virus gene amplification by heparin. J Clin Microbiol (1991) 3.32
Structure of the transmembrane region of the M2 protein H(+) channel. Protein Sci (2001) 3.31
Identification of sequences in a yeast histone promoter involved in periodic transcription. Cell (1986) 3.22
Preventing ventricular fibrillation by flattening cardiac restitution. Proc Natl Acad Sci U S A (2000) 3.15
Disruption of alpha3 connexin gene leads to proteolysis and cataractogenesis in mice. Cell (1997) 3.10
An Arabidopsis brassinosteroid-dependent mutant is blocked in cell elongation. Plant Cell (1998) 2.96
Weighted-ensemble Brownian dynamics simulations for protein association reactions. Biophys J (1996) 2.87
Predicting protein diffusion coefficients. Proc Natl Acad Sci U S A (1993) 2.87
Retracted Calmodulin kinase determines calcium-dependent facilitation of L-type calcium channels. Nat Cell Biol (2000) 2.86
Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc Natl Acad Sci U S A (1991) 2.81
Genomic organization of Borna disease virus. Proc Natl Acad Sci U S A (1994) 2.74
Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res (1997) 2.72
Programmable matter by folding. Proc Natl Acad Sci U S A (2010) 2.65
Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet (1998) 2.65
Efficient expression of the Saccharomyces cerevisiae PGK gene depends on an upstream activation sequence but does not require TATA sequences. Mol Cell Biol (1986) 2.63
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
Identification of c-myc responsive genes using rat cDNA microarray. Cancer Res (2000) 2.62
AN APPROXIMATE CELL MODEL FOR LIQUID HYDROGEN, I. Proc Natl Acad Sci U S A (1962) 2.59
Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part i: morbidity and mortality monitoring. Circulation (2001) 2.56
Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J (2001) 2.55
Cerberus is a head-inducing secreted factor expressed in the anterior endoderm of Spemann's organizer. Nature (1996) 2.54
Interorganelle signaling is a determinant of longevity in Saccharomyces cerevisiae. Genetics (1999) 2.50
Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor. Development (2001) 2.43
Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood (2000) 2.42
Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated. J Virol (1994) 2.40
Constitutive and antibody-induced internalization of prostate-specific membrane antigen. Cancer Res (1998) 2.38
Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia (2011) 2.37
Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol (1999) 2.36
DNA looping generated by DNA bending protein IHF and the two domains of lambda integrase. Science (1989) 2.34
Trends in diet, nutritional status, and diet-related noncommunicable diseases in China and India: the economic costs of the nutrition transition. Nutr Rev (2001) 2.33
Lipid-alamethicin interactions influence alamethicin orientation. Biophys J (1991) 2.33
Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet (1999) 2.32
Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res (2000) 2.32
Regulation of the mating pheromone and invasive growth responses in yeast by two MAP kinase substrates. Curr Biol (1997) 2.32
Differential expression of cardiac titin isoforms and modulation of cellular stiffness. Circ Res (2000) 2.28
PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells. J Biol Chem (2000) 2.26
High-throughput genotyping of single nucleotide polymorphisms with rolling circle amplification. BMC Genomics (2001) 2.25
Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat Med (1997) 2.24
Fracture of brittle metallic glasses: brittleness or plasticity. Phys Rev Lett (2005) 2.21
A transgenic rabbit model for human hypertrophic cardiomyopathy. J Clin Invest (1999) 2.19
Ginsenoside-Rd improves outcome of acute ischaemic stroke - a randomized, double-blind, placebo-controlled, multicenter trial. Eur J Neurol (2012) 2.18
Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. Hepatology (1999) 2.16
Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect Immun (1997) 2.16
KORRIGAN, an Arabidopsis endo-1,4-beta-glucanase, localizes to the cell plate by polarized targeting and is essential for cytokinesis. Plant Cell (2000) 2.15
An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies. Oncogene (2010) 2.14
Function of the c-Myc oncogenic transcription factor. Exp Cell Res (1999) 2.11
Turnover of soluble proteins in the wheat sieve tube. Plant Physiol (1992) 2.11
Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models. Mol Biochem Parasitol (2000) 2.10
Hydrodynamic steering effects in protein association. Proc Natl Acad Sci U S A (1994) 2.09
Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest (2000) 2.08
Fibroproliferation and mast cells in the acute respiratory distress syndrome. Thorax (1998) 2.08
Cycloplegic refractions in healthy children aged 1 through 48 months. Arch Ophthalmol (2001) 2.07
Protein kinase A phosphorylates titin's cardiac-specific N2B domain and reduces passive tension in rat cardiac myocytes. Circ Res (2002) 2.07
Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol (1996) 2.05
Structure and expression of a smooth muscle cell-specific gene, SM22 alpha. J Biol Chem (1995) 2.05
Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family. Cell (1996) 2.04
Inactivation of AtRac1 by abscisic acid is essential for stomatal closure. Genes Dev (2001) 2.02
Longitudinal vitamin D status in pregnancy and the risk of pre-eclampsia. BJOG (2012) 2.01
Cinnamon zeylanicum bark extract and powder mediated green synthesis of nano-crystalline silver particles and its bactericidal activity. Colloids Surf B Biointerfaces (2009) 2.01
Loss of presenilin 1 is associated with enhanced beta-catenin signaling and skin tumorigenesis. Proc Natl Acad Sci U S A (2001) 2.00
Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes (1997) 2.00
Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins. J Virol (1999) 1.97
Protein methylation. Science (1971) 1.95
Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn. J Biol Chem (1993) 1.95
4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors. J Med Chem (2000) 1.94
Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism. Clin Pharmacol Ther (1999) 1.94
Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment. Ann Oncol (2008) 1.92
KN-93, an inhibitor of multifunctional Ca++/calmodulin-dependent protein kinase, decreases early afterdepolarizations in rabbit heart. J Pharmacol Exp Ther (1998) 1.91
Gene activation by recruitment of the RNA polymerase II holoenzyme. Genes Dev (1996) 1.90
Alterations of the lymphocyte-specific protein tyrosine kinase (p56lck) during T-cell activation. Mol Cell Biol (1988) 1.90
Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proc Natl Acad Sci U S A (2001) 1.90